Eli Lilly's next-gen anti-obesity candidate hit it out of the park in a phase 3 study. This should help solidify the company's lead in this niche of the industry. Even after their strong run, Lilly's ...

These two healthcare stocks are top names to invest in, but they haven't both been doing well of late. Eli Lilly has generated $25 billion in revenue from its fast-growing GLP-1 drugs this year. Novo ...

What To Know: Novo Nordisk, one of Eli Lilly’s main competitors, announced a regulatory breakthrough for an oral weight loss drug. The FDA approved the company’s pill form of Wegovy, making it the ...

Aktis Oncology (AKTS), a radiopharmaceutical drug developer backed by pharma giants such as Eli Lilly (LLY), has filed its preliminary regulatory filings with the Securities and Exchange Commission ...

In the latest weekly data update, Eli Lilly's quality score advanced from 89.66 to 90.04. This uptick pushes the stock into the “elite” tier of the market, ranking it higher than 90% of its peers.

Eli Lilly (LLY) submitted an FDA application for orforglipron. The once-daily oral pill maintained weight loss after patients switched from injections. Lilly’s Zepbound achieved 20.2% average weight ...

Lily Collins was born into the entertainment world. She made her film debut in The Blind Side in 2009 and later earned a Golden Globe nomination for Warren Beatty’s Rules Don’t Apply in 2016. She went ...

Behind the scenes, Lily Collins had a très magnifique new pal when filming the new season of “Emily in Paris”: her baby girl. The star of Netflix’s fashion-focused dramedy (now streaming its fifth ...

"Emily in Paris" season five is streaming now. Spoiler alert: If you haven't seen "Emily in Paris" season 5 yet, look away now. The new season of "Emily in Paris" is putting Emily and Mindy's ...

Here's how the next generation of obesity drugs getting closer to patients differs from Wegovy and Zepbound Novo Nordisk (whose injectable weight-loss medication Wegovy is shown here) and rival Eli ...

"I've learned how horrible it is to be on the receiving end of that," Allen said in an 'Observer UK' interview on Saturday, Dec. 20 Ilana Kaplan is a Staff Editor at PEOPLE. She has been working at ...